Advertisement
Australia markets closed
  • ALL ORDS

    8,153.70
    +80.10 (+0.99%)
     
  • ASX 200

    7,896.90
    +77.30 (+0.99%)
     
  • AUD/USD

    0.6510
    -0.0008 (-0.13%)
     
  • OIL

    83.11
    -0.06 (-0.07%)
     
  • GOLD

    2,254.80
    +16.40 (+0.73%)
     
  • Bitcoin AUD

    107,942.93
    +892.65 (+0.83%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • AUD/EUR

    0.6037
    +0.0003 (+0.05%)
     
  • AUD/NZD

    1.0901
    -0.0001 (-0.01%)
     
  • NZX 50

    12,105.29
    +94.63 (+0.79%)
     
  • NASDAQ

    18,254.69
    -26.15 (-0.14%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • Dow Jones

    39,807.37
    +47.29 (+0.12%)
     
  • DAX

    18,492.49
    +15.40 (+0.08%)
     
  • Hang Seng

    16,541.42
    +148.58 (+0.91%)
     
  • NIKKEI 225

    40,402.73
    +234.66 (+0.58%)
     

European equities rise on takeover news

Frankfurt's DAX 30 index rose 0.59 percent to finish at 10,164.31 points

Takeover news buoyed European stock markets Tuesday, with sentiment also boosted by bargain-hunting after recent China-inspired losses, dealers said.

London's benchmark FTSE 100 index of blue-chip companies won 0.77 percent to close at 6,555.28 points, encouraged also by data showing the British economy rebounded by 0.7 percent in the second quarter.

Frankfurt's DAX 30 added 1.06 percent to end the day at 11,173.91 points, and the CAC 40 in Paris rose 1.01 percent to 4,977.32 points compared with Monday's close.

In foreign exchange, the euro nudged lower to $1.1049 from $1.1091 late in New York on Monday.

ADVERTISEMENT

Zurich Insurance confirmed speculation that it is interested in buying British rival Royal & Sun Alliance.

In reaction, RSA shares surged by 17.75 percent to close at 515.5 pence, easily topping the FTSE leaderboard.

The pharmaceuticals sector was also in focus as London-listed group Hikma bought US generic drugs company Roxane from German peer Boehringer Ingelheim for $2.65 billion (2.40 billion euros) in the sector's latest rapid round of consolidation.

The deal will transform Hikma into the sixth largest player in the US generics market, in terms of revenue, said a statement from Hikma, which is based in Amman, Jordan.

Hikma's London share price jumped 11.59 percent to close at 2,321 pence following the news.

Generic drug companies are under pressure to do deals because there are fewer big-money drugs shifting to generic status after patents expires compared with a few years ago.

The deal comes one day after Israeli pharmaceutical giant Teva snapped up the generic drugs business of Allergan for $40.5 billion, consolidating its position as a world leader in generics.

- 'Relative calm in China' -

"Bid activity, strong corporate results and relative calm in China helped confidence return to European equities on Tuesday after a week-long slump," said Jasper Lawler, market analyst at CMC Markets UK.

Meanwhile, shares in British engineering firm GKN jumped 7.32 percent to 316.60 pence after it agreed to purchase Dutch aerospace company Fokker Technologies Group.

European equities also rebounded Tuesday as investors fished for bargain stocks.

"The fact that we?re coming off the back of five consecutive daily declines (in London) has prompted some bargain-hunting on the part of some investors," noted analyst Michael Hewson at trader CMC Markets.

The region's equity markets had fallen sharply on Monday as investors reacted to the biggest one-day plunge in Chinese equities in more than eight years.

However, Asian indices mostly fell again Tuesday, with Shanghai seeing another round of wild volatility with stocks ending 1.68 percent lower, after having collapsed by 8.48 percent on Monday.

For its part, Hong Kong -- which sank more than three percent on Monday -- clawed back early losses to end up 0.62 percent.

Elsewhere, Tokyo dipped 0.10 percent and Sydney edged down 0.09 percent.

Chinese investors rushed for the exit Monday as more data showing the economy still struggling combined with fears that government measures to prevent a market crash -- including providing vast sums to support shares -- would not last.

Like European markets, Wall Street shrugged off the pessimism in Asia, with US stocks also rising on Tuesday.

In midday trades in New York, the Dow Jones Industrial Average was up 0.76 percent, the broad-market S&P 500 advanced 0.80 percent, while the tech-rich Nasdaq Composite Index rose 0.52 percent.

Investors were also awaiting this week's US Federal Reserve's monetary policy meeting for a handle on its plans for interest rates. The Fed will announce the outcome on Wednesday.